68 filings
6-K
INCR
Intercure Ltd
1 May 24
Current report (foreign)
7:10am
20-F
2023 FY
INCR
Intercure Ltd
Annual report (foreign)
1 May 24
7:05am
NT 20-F
INCR
Intercure Ltd
1 May 24
Notice of late annual filing (foreign)
7:02am
6-K
INCR
Intercure Ltd
1 Apr 24
InterCure Announces Preliminary Estimated 2023 Revenue of NIS 351 million and EBIDTA of over NIS 50 million
8:40am
6-K
INCR
Intercure Ltd
13 Feb 24
InterCure Provides an Update Regarding Nir Oz Facility
4:56pm
6-K
uud2nq15yp4mwzv2yu
13 Feb 24
Current report (foreign)
4:30pm
6-K
860cesg75
31 Jan 24
InterCure Signs Definitive Agreement to Acquire Leon Cannabis Pharmacy Chain
9:00am
6-K
i50qj2lhvqu3h p9ocm5
14 Dec 23
Current report (foreign)
4:30pm
6-K
gmms3
8 Nov 23
Annual General Meeting of Shareholders to Be
4:30pm
6-K
epsimw2nspw0p7el4r
31 Oct 23
Current report (foreign)
4:51pm
6-K
3bvoo
17 Oct 23
InterCure Provides an Update Regarding the Security Situation in Israel
5:20pm
6-K
hqxatios7ni
31 Aug 23
InterCure Announces Record Revenues First Half of 2023 with over 14% growth YOY
5:28pm
6-K
dizmy
14 Aug 23
Current report (foreign)
4:30pm
6-K
zuo2ytwpf 5218mbh
24 Jul 23
Notice of Special Meeting of Shareholders
5:00pm
6-K
0grjpvsai030
11 Jul 23
InterCure Ltd. Announces Proposed Voluntary Delisting from the Toronto Stock Exchange and shall continue to be listed on the NASDAQ and TASE
6:02am
6-K
2c4jr
12 Jun 23
InterCure Provides an Update About The Lawsuit it Filed Against Cann Pharmaceuticals to Recover Funds Following Failed Merger
8:00am
6-K
f0b7 f65oph6bqr2bqr
16 May 23
InterCure Announces Record Breaking First Quarter Revenues with 22% growth YOY
6:06am
6-K
5xozjr5 6z4mk4ta42
26 Apr 23
InterCure Informs That A Lawsuit Was Filed Against the Company by Minority Shareholders of Its Subsidiary
8:00am
6-K
exbx3yi9
25 Apr 23
Current report (foreign)
8:00am